Abstract
Background In patients treated by left ventricular assist device (LVAD), aortic regurgitation
(AR) may occur. Secondary surgery to correct AR is considered high risk.
Case Description We report a case of severe AR following LVAD implantation in a patient who was subsequently
treated by transcatheter aortic valve implantation (TAVI) using the latest generation
self-expandable transcatheter heart valve (THV) (Boston Scientific Acurate neo, size
M [Boston Scientific, Marlborough, Massachusetts, United States]). TAVI followed modified
procedural protocol and sizing algorithm. THV implantation without prior balloon aortic
valvuloplasty resulted in an adequate valve function without leakage.
Conclusion This THV may be particularly well suited for TAVI subsequent to LVAD implantation
if modified sizing and deployment considerations are appreciated.
Keywords
left ventricular assist device - aortic regurgitation - transcatheter aortic valve
implantation - heart failure
